Veracyte VCYT
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$30.91M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 45.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.45% to 11.89% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Congress Asset Management Company, LLP | Mutual Fund | 2026/Q3 | +1,954,198 | 2.4% |
| William Blair Investment Management, LLC | Mutual Fund | 2026/Q3 | +1,274,053 | 3.6% |
| GW&K Investment Management, LLC | Mutual Fund | 2026/Q3 | +992,760 | 3.0% |
| Vaughan Nelson Investment Management, L.P. | Mutual Fund | 2026/Q3 | +965,710 | 1.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +834,609 | 6.9% |
| Loomis, Sayles & Company L.P. | Mutual Fund | 2026/Q3 | +671,355 | 0.8% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +668,699 | 3.7% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +661,382 | 0.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +400,751 | 17.2% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +253,091 | 0.4% |
| Connor, Clark & Lunn Investment Management Ltd. | Mutual Fund | 2026/Q3 | +192,787 | 0.3% |
| CW Advisors, LLC | Mutual Fund | 2026/Q3 | +181,367 | 0.2% |
| The Renaissance Group LLC | Mutual Fund | 2026/Q3 | +180,351 | 0.2% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +152,012 | 0.6% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +126,757 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | Jonathan Wygant | Vice President | Sale to Issuer | -1,306 | $50.31 | 13,003 |
| 26 Oct 2026 | Karin Eastham | Independent Director | Open Market Disposition | -4,850 | $50.00 | 4,975 |
| 26 Oct 2026 | Karin Eastham | Independent Director | Intent to Sell (Form 144) | -14,850 | $48.20 | – |
| 26 Oct 2026 | Karin Eastham | Independent Director | Derivative Exercise and Sale | -10,000 | $50.00 | 4,975 |
| 26 Oct 2026 | Jens Holstein | Independent Director | Intent to Sell (Form 144) | -7,500 | $50.00 | – |
| 26 Oct 2026 | Jens Holstein | Independent Director | Derivative Exercise and Sale | -15,000 | $50.00 | 22,199 |
| 18 Oct 2026 | Muna Bhanji | Independent Director | Automatic Disposition | -1,864 | $43.70 | 35,582 |
| 23 Sep 2026 | Jens Holstein | Independent Director | Intent to Sell (Form 144) | -7,500 | $47.00 | – |
| 20 Sep 2026 | John Leite | Global Chief Commercial Officer | Automatic Disposition | -4,015 | $40.00 | 8,316 |
| 13 Sep 2026 | Jens Holstein | Independent Director | Automatic Disposition | -5,000 | $40.95 | 22,199 |
| 3 Sep 2026 | Phillip Febbo | Chief Scientific & Medical Officer | Open Market Disposition | -13,110 | $43.66 | 26,241 |
| 3 Sep 2026 | Rebecca Chambers | Chief Financial Officer | Open Market Disposition | -3,652 | $43.71 | 36,201 |
| 3 Sep 2026 | Annie McGuire | Executive VP, General Counsel & Head of Market Access | Open Market Disposition | -3,254 | $43.67 | 1,519 |
| 1 Sep 2026 | Phillip Febbo | Chief Scientific & Medical Officer | Sale to Issuer | -3,639 | $44.88 | 26,241 |
| 1 Sep 2026 | Marc Stapley | Chief Executive Officer | Sale to Issuer | -8,782 | $44.88 | 161,736 |
| 1 Sep 2026 | Jonathan Wygant | Vice President | Sale to Issuer | -1,361 | $44.88 | 11,423 |
| 1 Sep 2026 | Rebecca Chambers | Chief Financial Officer | Sale to Issuer | -3,603 | $44.88 | 36,201 |
| 1 Sep 2026 | John Leite | Global Chief Commercial Officer | Sale to Issuer | -3,961 | $44.88 | 12,331 |
| 1 Sep 2026 | Annie McGuire | Executive VP, General Counsel & Head of Market Access | Sale to Issuer | -3,215 | $44.88 | 1,519 |
| 31 Aug 2026 | Muna Bhanji | Independent Director | Automatic Disposition | -1,864 | $42.97 | 37,446 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,559,148 | 11.9% | 8.2 |
| 15 Oct 2026 | 9,821,453 | 12.2% | 8.5 |
| 30 Sep 2026 | 10,178,975 | 12.7% | 5.9 |
| 15 Sep 2026 | 8,403,932 | 10.5% | 7.8 |
| 31 Aug 2026 | 8,077,228 | 10.0% | 5.8 |
| 14 Aug 2026 | 6,789,714 | 8.4% | 5.6 |
No comments yet — be the first to weigh in on VCYT.
Sign in to join the discussion.